维贝格龙不同版本一盒的最新价格公布

Vibegron is an innovative drug used to treat overactive bladder (OAB). By activating β3 adrenergic receptors, it promotes detrusor muscle relaxation, increases bladder capacity and storage capacity, and reduces OAB symptoms such as urinary urgency, frequency, and urge urinary incontinence. This article will introduce the latest information on Vibegroron in detail from three aspects: drug price, domestic listing status and medical insurance reimbursement, to help patients and family members better understand this drug.

The latest prices for a box of different versions of Vibegroron

There are obvious differences in prices in the global market. Understanding this price information can help patients make economically reasonable drug purchasing decisions.

Price of Lucius version in Laos

Vibegron produced by Lucius in Laos has a specification of 75mg*30 tablets and the price is about US$158 per box. This version has become the first choice for many patients because of its relatively favorable price.

Original drug price

The price of Vibegroron produced by the original manufacturer is generally higher in developed countries such as Europe and the United States, and the specific price is temporarily unclear.

Price of generic drugs

Vibegroron produced in Lucius, Laos, has a specification of 75mg*30 tablets and the price is about US$158 per box. There may be slight differences in the production processes of different generic drug manufacturers.

The price difference is mainly due to factors such as research and development costs, production technology and regional economic level. Patients should choose the appropriate version according to their own circumstances. The above prices are for reference only.

The domestic marketing status of Vibegroron

The domestic marketing status of Vibegroron directly affects the accessibility of the drug to patients, and it is very necessary to understand the relevant policies.

Domestic Approval Status

As of now, Vibegroron has not yet received marketing approval from the China National Medical Products Administration, and the drug cannot be provided in regular domestic hospital pharmacies.

Access methods

Patients in need mainly obtain it in two ways. One is through the "franchised medical" policy of medical pioneer zones such as Boao Lecheng in Hainan; the other is through individual cross-border drug purchase channels, such as overseas medical treatment and overseas drug purchase.

There are quality risks in medicines purchased through informal channels. It is recommended that patients take medications under the guidance of professional doctors and try to choose reliable drug purchasing channels.

The medical insurance reimbursement status of Vibegroron

The medical insurance reimbursement policy directly affects the financial burden of patients, and it is necessary to understand the current reimbursement status of Vibegroron.

National Medical Insurance Catalog

Vibegron is currently not included in my country’s National Medical Insurance Drug Catalog and cannot be reimbursed by medical insurance, which means that patients need to pay for the drug entirely out of their own pocket.

Commercial insurance coverage

Some high-end commercial medical insurance may cover the cost of Vibegroron treatment. Please check the insurance terms for details. Patients are advised to consult their insurance company in advance.

In the absence of medical insurance reimbursement, patients need to comprehensively evaluate the affordability of treatment and formulate a reasonable medication plan.